US urged UK to offer better drug pricing deal to pharma companies
Ambassador’s meeting with chancellor Rachel Reeves came days before AstraZeneca and Merck paused projects in Britain
Related reading
Britain is squeezing AstraZeneca too tight
NHS curbs on drug prices have alienated UK pharma companies and become self-defeating
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
AstraZeneca revives Cambridge investment after UK agrees to pay more for drugs
Resumption of £300mn in UK projects is a result of trade deal with US that aims to increase medicines spending
NHS to increase medicines spending to avoid threatened Trump tariffs
UK government will make it easier for drugs to be approved for use in order to secure carve-out from import levies
Eli Lilly pushes for NHS drug price increases in return for its UK investment
US pharmaceutical group ‘optimistic’ about reaching deal with British government
AstraZeneca strikes deal to lower drug costs in exchange for tariff reprieve
Chief executive Pascal Soriot applauds the deal with Donald Trump as ‘a big win’ for US patients